New fibroblast activation protein inhibitor, CPD60, attenuates fibrosis and chronic liver disease progresion in CCL4 induced liver fibrosis, but not in MDR2-/- mice

被引：0

作者：

Yang, Ai Ting ^{[1
,2
,3
]}

Kim, Yong Ook ^{[2
,3
]}

Aslam, Misbah ^{[2
,3
]}

Giardino, Mariacristina ^{[2
,3
]}

Abe, Hiroyuki ^{[2
,3
]}

Park, Kyoung Sook ^{[2
,3
]}

Khan, Muhammad Ashfaq ^{[2
,3
]}

You, Hong ^{[1
]}

Jia, Ji Dong ^{[1
]}

Klein, Thomas ^{[4
]}

Schuppan, Detlef ^{[2
,3
,5
]}

机构：

[1] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China

[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Translat Immunol, Mainz, Germany

[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany

[4] Boehringer Ingelheim GmbH & Co KG, Cardiometabol Res, Biberach, Germany

[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30384-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-104

引用

页码：E206 / E206

页数：1

共 50 条

[21] HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE [J].

Schroder, Vanessa T. ;

Rangwala, Fatima ;

Syn, Wing-Kin ;

Guy, Cynthia D. ;

Karaca, Gamze F. ;

Diehl, Anna Mae .

HEPATOLOGY, 2010, 52 (04) :1146A-1146A

[22] Targeted disruption of TGF-B activation by an AVB1 integrin inhibitor significantly reduces liver fibrosis in CCl4 mice and Human NASH liver slices [J].

Schaub, Johanna ;

Decaris, Martin ;

Reilly, Maureen ;

Lee, Gail ;

Martin, Shamra ;

Rao, Vickram ;

Chen, Chun ;

Rexhepaj, Meghi ;

Kotak, Perna ;

Hooi, Lisa ;

Leftheris, Katarina ;

Cha, Jake ;

Lepist, Irene ;

Andre, Patrick ;

Turner, Scott .

JOURNAL OF HEPATOLOGY, 2019, 70 (01) :E57-E58

[23] Anthocyanins isolated from blueberry ameliorates CCl4 induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice [J].

Sun, Jianchao ;

Wu, Yafeng ;

Long, Cuizhen ;

He, Ping ;

Gu, Junying ;

Yang, Lei ;

Liang, Yaodong ;

Wang, Yuping .

FOOD AND CHEMICAL TOXICOLOGY, 2018, 120 :491-499

[24] PHARMACOLOGICAL EFFECTS OF ACETYL SALICYLIC ACID, SULFASALAZINE, IBUPROFEN AND CELECOXIB ON LIVER FIBROSIS INDUCED BY CHRONIC ADMINISTRATION OF CCL4 [J].

Chavez, E. ;

Moreno, M. G. ;

Muriel, P. .

JOURNAL OF HEPATOLOGY, 2009, 50 :S272-S272

[25] Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice [J].

Wu, Kangkang ;

Huang, Rui ;

Wu, Hongyan ;

Liu, Yong ;

Yang, Chenchen ;

Cao, Shufeng ;

Hou, Xianglin ;

Chen, Bing ;

Dai, Jianwu ;

Wu, Chao .

MOLECULAR MEDICINE REPORTS, 2016, 14 (05) :4680-4686

[26] The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice [J].

Abu-Elsaad, Nashwa M. ;

Serrya, Marwa S. ;

El-Karef, Amr M. ;

Ibrahim, Tarek M. .

PHARMACOLOGICAL REPORTS, 2016, 68 (02) :275-282

[27] The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice [J].

Nashwa M. Abu-Elsaad ;

Marwa S. Serrya ;

Amr M. El-Karef ;

Tarek M. Ibrahim .

Pharmacological Reports, 2016, 68 :275-282

[28] Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway [J].

Li, Jiahuan ;

Deng, Xiaoling ;

Wang, Shuhan ;

Jiang, Qianqian ;

Xu, Keshu .

FRONTIERS IN PHARMACOLOGY, 2021, 12

[29] NOX1/4 Inhibition Attenuates Myofibroblast Activation and Liver Fibrosis in MDR2 Deficient Mice, a Model of Progressive Cholangiopathy [J].

Nishio, Takahiro ;

Liang, Shuang ;

Mccubbin, Ryan ;

Kisseleva, Tatiana ;

Brenner, David A. .

HEPATOLOGY, 2018, 68 :642A-643A

[30] GUT-DERIVED BACTERIAL PRODUCTS DRIVE PROGRESSION OF LIVER FIBROSIS IN MDR2-/- MICE: INVOLVEMENT OF LPS AND TLR4 [J].

Poelstra, Klaas ;

Popov, Yury ;

Sverdlov, Deanna Y. ;

Sharma, Anisha ;

Schuppan, Detlef .

HEPATOLOGY, 2009, 50 (04) :819A-819A

← 1 2 3 4 5 →